Andrew Blumenthal advises corporate, private equity, and banking clients on capital markets, securities, and corporate governance matters.  

Mr. Blumenthal handles a variety of public and private domestic and cross-border financing transactions, as well as public company governance and reporting issues.

His practice includes: 

  • Equity-linked securities offerings
  • Follow-on and secondary equity offerings
  • Initial public offerings 
  • Investment-grade and high-yield debt offerings 
  • US Securities and Exchange Commission (SEC) and stock exchange-related matters 

Mr. Blumenthal works on matters across various industries and regions.

Mr. Blumenthal’s experience includes advising:

  • Broadcom on its offerings of mandatory convertible preferred stock and investment-grade notes
  • Leonard Green & Partners on its convertible preferred stock investment in Catalent 
  • The underwriters and initial purchasers on several convertible note offerings by, among others, Lumentum, The Chefs’ Warehouse, Winnebago, Cytokinetics, Halozyme, Aerie Pharmaceuticals, and Mesa Laboratories
  • The underwriters in Danaher’s concurrent offering of mandatory convertible preferred stock and common stock
  • Several issuer clients on convertible notes offerings, including Encore Capital Group, Live Nation Entertainment, and Teradyne
  • The underwriters on the offering of American depositary shares by GDS Holdings

Bar Qualification

  • New York

Education

  • JD, Georgetown University, 2014
    cum laude
  • BBA International Finance & Marketing, University of Miami, 2011
    magna cum laude